I.R.Clinic, UAB - financials and debts

Company age: 34 y. 6 mo.

Update

I.R.Clinic - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 196,500 151,134 173,466 173,466 295,095 313,861 291,543 271,077
Profit before tax - - 45,351 45,351 65,340 128,575 152,534 66,228
Net profit 62,228 15,837 43,083 43,083 62,073 109,289 144,907 62,254
Equity 167,684 183,522 226,605 226,605 245,763 292,156 357,063 359,318
Liabilities 4,313 7,159 17,117 17,117 30,453 40,926 30,544 20,633
Non-current assets 43,646 37,287 30,972 30,972 12,076 4,802 3,692 3,005
Current assets 128,351 153,394 212,750 212,750 264,140 328,280 383,915 376,946
Total assets 171,997 190,681 243,722 243,722 276,216 333,082 387,607 379,951
Taxes paid
STI taxes - - - - - 31,406 34,008 18,932
Social insurance contributions - - - - - 9,431 11,918 12,410
Financial indicators
Revenue change y/y +50.4% -23.1% +14.8% +0.0% +70.1% +6.4% -7.1% -7.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 36.2% 8.3% 17.7% 17.7% 22.5% 32.8% 37.4% 16.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 37.1% 8.6% 19.0% 19.0% 25.3% 37.4% 40.6% 17.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 31.7% 10.5% 24.8% 24.8% 21.0% 34.8% 49.7% 23.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - 26.1% 26.1% 22.1% 41.0% 52.3% 24.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 31,440 25,189 28,911 33,041 59,019 62,772 58,309 54,215

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

I.R.Clinic - Social security debts

From To Debt, €
2026-07-19 2026-08-06 0.06
2026-07-16 2026-07-17 0.06
2026-06-16 2026-06-29 0.06
2026-05-17 2026-05-31 0.06
2026-04-24 2026-04-29 0.06
2026-02-18 2026-03-01 22.44
2026-01-16 2026-01-29 0.04
2025-12-16 2025-12-28 0.04
2025-11-18 2025-11-30 0.04
2025-10-23 2025-11-02 0.04
2025-09-16 2025-09-24 12.24
2025-08-19 2025-08-29 0.03
2025-07-24 2025-07-28 0.03
2025-07-16 2025-07-23 3.28
2025-06-17 2025-06-30 3.28
2025-05-16 2025-06-01 3.28
2025-05-04 2025-05-05 0.01
2025-05-01 2025-05-01 0.01
2025-04-24 2025-04-29 0.01
2025-03-03 2025-03-03 6.25
2025-02-18 2025-02-27 6.25
2025-02-10 2025-02-10 4.19
2025-01-16 2025-01-30 4.19
2024-08-19 2024-08-27 41.53
2024-05-16 2024-05-28 997.32
2023-08-21 2023-08-31 171.98
2023-06-16 2023-07-12 2.98
2023-05-22 2023-05-31 2.98
2023-05-16 2023-05-21 119.50
2023-05-02 2023-05-03 119.50
2023-04-26 2023-04-28 119.50
2023-04-18 2023-04-25 119.45
2023-03-16 2023-04-16 2.93
2023-02-17 2023-02-28 2.93
2023-01-24 2023-02-01 2.93
2023-01-23 2023-01-23 2.91
2023-01-20 2023-01-22 2.93
2023-01-17 2023-01-19 2.91
2022-12-16 2022-12-28 2.91
2022-11-21 2022-11-24 2.91
2022-11-17 2022-11-18 2.91
2022-10-28 2022-10-30 0.49
2022-08-23 2022-08-29 54.33
2022-01-18 2022-01-18 766.06
2021-11-16 2021-11-17 719.34

I.R.Clinic - VMI tax arrears

From To Overdue, €
2025-09-22 2025-09-25 1683.75
2025-09-17 2025-09-21 1788.75

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
I.R.Clinic, UAB (code 121260333) is a Private Limited Liability Company engaged in dental practice care activities. In the latest financial year, 2025, the company generated revenue of €271.1K and net profit of €62.3K, giving a profit margin of 23.0%. Revenue declined from €313.9K in 2023 to €291.5K in 2024 and then to €271.1K in 2025, while net profit remained strong over the period, rising from €109.3K in 2023 to €144.9K in 2024 before easing to €62.3K in 2025. The balance sheet remained solid, with total assets of €380.0K, equity of €359.3K and liabilities of €20.6K in 2025. The equity ratio stood at 94.6% and debt to equity at 0.06, indicating a very low leverage position. Return on equity was 17.3% and return on assets 16.4%, while asset turnover was 0.71x. Revenue per employee was €54.2K and profit per employee was €12.5K, pointing to reasonable productivity in 2025.